1.Ling Mei*. Bio-Camouflaged Nanoreactors with Spatiotemporally Controlled Cu2+-Fenton Catalysis for Enhanced Starvation-Augmented Mild Photothermal Therapy. Science China Materials. 2026, 69(6): 3652-3665.
2.Ling Mei*, Kelong Fan*. Beyond Enzyme Mimics: Engineering Photo-Responsive Nanozymes for Therapeutic Innovation. Adv Mater. 2026, 38(3): e10661.
3.Ling Mei*, Zhenxing Wang*. Harnessing nanozymes as next-generation antimicrobial agents: From mechanisms to therapeutic strategies. Materials Today Bio. 2025,35: 102499.
4.Ling Mei, Man Li*, Qin He*. Self-propelled smart nanomotors for enhanced mild photothermal therapy of tumors through autophagy modulation. Acta Biomater. 2025, 201: 574-590.
5.Ling Mei*. Engineering a Multifunctional Nanozyme Platform for Synergistic Melanoma Therapy: Integrating Enzyme Activity, Immune Activation, and Low-Temperature Photothermal Effects. Angew. Chem. Int. Ed. 2025, 137(32): e202505911.
6.Man Li*, Qin He*, Ling Mei*. Integration of Photodiagnosis and Therapy Guided by Micro/Nanorobots. Adv Mater. 2025, 37(18): 2420359.
7.Man Li*, Qin He*, Ling Mei*. Innovative integration of nanomedicines and phototherapy to modulate autophagy for enhanced tumor eradication. J Control Release, 2025, 377: 855-879.
8.Ling Mei, Jong Seung Kim*. Self-propelling intelligent nanomotor: A dual-action photothermal and starvation strategy for targeted deep tumor destruction. Biomaterials. 2025, 315: 122968.
9.Ling Mei*, Ben Zhong Tang*. From Light to Cure: Precision Phototherapies for Antibiotic-Refractory Biofilm Infections. Angew. Chem. Int. Ed. 2025, 64(43): e202510900.
10.Ling Mei, Pengfei Zhang*. Nanozymes for Non-Neoplastic Diseases: Catalytic Therapy Redefined. Aggregate, 2025, e70150.
11.Ling Mei, Tao Song*. Nanomaterials at the forefront of antimicrobial therapy by photodynamic and photothermal strategies. Mater. Today Bio, 2024,29: 101354.
12.Haojun Li1, Ling Mei1*, Yuxin Xie, Siqi Huang, Xue Shen*. Liposome-like Nanoplatform Regulates Autophagy to Enhance Antitumor Chemo-Immunotherapy. ACS Appl. Nano Mater. 2024, 7(22), 25447-25458.
13.Ling Mei, Qin He*. Effective treatment of the primary tumor and lymph node metastasis by polymeric micelles with variable particle sizes. J Control Release, 2018, 292: 67-77.
14.Ling Mei, Qin He*. Enhanced tumor retention effect by click chemistry for improved cancer immunochemotherapy. ACS Appl. Mater Inter, 2018, 10(21):17582-17593.
15.Ling Mei, Qin He*. Polymer−drug nanoparticles combine doxorubicin carrier and heparin bioactivity functionalities for primary and metastatic cancer treatment. Mol Pharm, 2017, 14(2):513-522.
16. Ling Mei, Qin He*. Antitumor and antimetastasis activities of heparin-based micelle served as both carrier and drug. ACS Appl. Mater Inter, 2016, 8(15):9577-9589.
17. Ling Mei, Qin He*. Enhanced antitumor and anti-metastasis efficiency via combined treatment with CXCR4 antagonist and liposomal doxorubicin. J Control Release, 2014 (196):324-331.
